Evidence map›Paper›PMID 36185970›Full record

ArticleJournal of global health reports2022

Estimating the prevalence of COPD in an African country: evidence from southern Nigeria.

Boni M Ale, Obianuju B Ozoh, Muktar A Gadanya, Yiyang Li, Michael O Harhay, Akindele O Adebiyi, Davies Adeloye

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of global health reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06029543 (Permian Health Women's Lung Health Study), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06029543 not yet recruitingnot on this mapstarted 2023, after this paper: background citation

Permian Health Women's Lung Health Study

Typeobservational_patient_registrySponsorPermian Health Lung InstituteRan2023 to 2026Enrolled350ConditionsCOPD, Lung Function Decreased, Alpha 1-Antitrypsin
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 3 countries.

Boni M AleCardiovascular Research Unit, University of Abuja, and University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria.
Obianuju B OzohDepartment of Medicine, College of Medicine, The University of Lagos and The Lagos University Teaching Hospital, Lagos, Nigeria.
Muktar A GadanyaDepartment of Community Medicine, Bayero University, Kano, Nigeria.
Yiyang LiDepartment of Statistics, University of Warwick, Warwick, UK.
Michael O HarhayDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Akindele O AdebiyiCollege of Medicine, University of Ibadan, Nigeria.
Davies AdeloyeCentre for Global Health, Usher Institute, University of Edinburgh, UK.
Bayero University Kano · NGUniversity of Abuja Teaching Hospital · NGUniversity of Edinburgh · GBUniversity of Ibadan · NGUniversity of Lagos · NGUniversity of Pennsylvania · USUniversity of Warwick · GB

Funding

Improving the measurement and analysis of long-term, patient-centered outcomes following acute respiratory failureK99HL141678 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI HARHAY, MICHAEL OSCAR · 2018 to 2019
$214k
NHLBI NIH HHS K99 HL141678
6 · The paper itself

Abstract

# Background: Though several environmental and demographic factors would suggest a high burden of chronic obstructive pulmonary disease (COPD) in most African countries, there is insufficient country-level synthesis to guide public health policy. # Methods: A systematic search of MEDLINE, EMBASE, Global Health and African Journals Online identified studies reporting the prevalence of COPD in Nigeria. We provided a detailed synthesis of study characteristics, and overall median and interquartile range (IQR) of COPD prevalence in Nigeria by case definitions (spirometry or non-spirometry). # Results: Of 187 potential studies, eight studies (6 spirometry and 2 non-spirometry) including 4,234 Nigerians met the criteria. From spirometry assessment, which is relatively internally consistent, the median prevalence of COPD in Nigeria was 9.2% (interquartile range, IQR: 7.6-10.0), compared to a lower prevalence (5.1%, IQR: 2.2-15.4) from studies based on British Medical Research Council (BMRC) criteria or doctor's diagnosis. The median prevalence of COPD was almost the same among rural (9.5%, IQR: 7.6-10.3) and urban dwellers (9.0%, IQR: 5.3-9.3) from spirometry studies. # Conclusions: A limited number of studies on COPD introduces imprecision in prevalence estimates and presents concerns on the level of response available across different parts of Nigeria, and indeed across many countries in sub-Saharan Africa.

Indexed as

chronic respiratory diseaseCOPDepidemiologyNigeriaprevalence

Identifiers

PMID36185970
PMCPMC9521051
OpenAlexW4296094922

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.